Sartorius (OTCMKTS:SARTF – Get Free Report) was the target of a large decline in short interest in October. As of October 30th, there was short interest totaling 836 shares, a decline of 54.2% from the October 15th total of 1,827 shares. Based on an average daily volume of 0 shares, the short-interest ratio is currently ∞ days. Currently, 0.0% of the company’s stock are sold short.
Sartorius Stock Performance
Shares of SARTF stock opened at $261.99 on Tuesday. The company has a debt-to-equity ratio of 0.89, a quick ratio of 0.49 and a current ratio of 0.95. The company has a market capitalization of $8.97 billion, a P/E ratio of 121.85 and a beta of 0.98. The company’s 50 day moving average price is $242.59 and its two-hundred day moving average price is $224.22. Sartorius has a 52 week low of $181.58 and a 52 week high of $261.99.
Sartorius Company Profile
Sartorius is a life science company headquartered in Göttingen, Germany. Founded in 1870 as a precision-balance manufacturer, it has grown into a global supplier of technologies and services for biopharmaceutical production and laboratory research. The company’s bioprocessing products include filtration and fluid-management systems, single-use equipment, bioreactors, and technologies used in cell culture and purification. These solutions support the development and manufacture of biologic medicines, including vaccines and other advanced therapies.
Further Reading
- Five stocks we like better than Sartorius
- Tyson Foods’ Earnings Beat Hides a Warning for Consumer Staples Dividend Investors
- 3 Stocks in an Overlooked Corner of Infrastructure With Hundreds of Billions at Stake
- Tyson Foods’ 10% Surge Puts a Breakout in Sight, But Wall Street Remains Cautious
- Microsoft’s Outage Barely Moved Its Stock, But a Bigger Risk May Be Building
Receive News & Ratings for Sartorius Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sartorius and related companies with MarketBeat.com's FREE daily email newsletter.
